[T- and B-immunity system indices in candidiasis]. 1981

V A Krylov, and O L Pokrovskaia, and T A Krylova, and N D Iarobkova

The examination of 73 patients with superficial and visceral candidiasis and Candida-carriers yielded no data to the effect that the increased activity of opportunistic fungi of the genus Candida in the body was preceded by organic lesions in the T- and B-systems of lymphocytes. Only in 16 patients who had visceral candidiasis for 8-12 years with combined lesions of several organs the decreased capacity of lymphocytes for reacting with phytohemagglutinin was observed, which was probably a manifestation of the secondary immune insufficiency, developing in the presence of prolonged infection.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D002180 Candidiasis, Oral Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed) Moniliasis, Oral,Thrush,Candidiases, Oral,Moniliases, Oral,Oral Candidiases,Oral Candidiasis,Oral Moniliases,Oral Moniliasis
D002181 Candidiasis, Vulvovaginal Infection of the VULVA and VAGINA with a fungus of the genus CANDIDA. Moniliasis, Vulvovaginal,Vaginitis, Monilial,Candidiasis, Genital,Genital Vulvovaginal Candidiasis,Vaginal Yeast Infection,Vaginal Yeast Infections,Candidiasis, Genital Vulvovaginal,Genital Candidiasis,Infection, Vaginal Yeast,Infections, Vaginal Yeast,Monilial Vaginitis,Vulvovaginal Candidiasis,Vulvovaginal Candidiasis, Genital,Vulvovaginal Moniliasis,Yeast Infection, Vaginal,Yeast Infections, Vaginal

Related Publications

V A Krylov, and O L Pokrovskaia, and T A Krylova, and N D Iarobkova
May 1983, Vrachebnoe delo,
V A Krylov, and O L Pokrovskaia, and T A Krylova, and N D Iarobkova
February 2009, The Journal of experimental medicine,
V A Krylov, and O L Pokrovskaia, and T A Krylova, and N D Iarobkova
January 1984, Fiziologicheskii zhurnal,
V A Krylov, and O L Pokrovskaia, and T A Krylova, and N D Iarobkova
November 1991, Vrachebnoe delo,
V A Krylov, and O L Pokrovskaia, and T A Krylova, and N D Iarobkova
January 1978, Voprosy revmatizma,
V A Krylov, and O L Pokrovskaia, and T A Krylova, and N D Iarobkova
September 1983, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
V A Krylov, and O L Pokrovskaia, and T A Krylova, and N D Iarobkova
May 1983, Vestnik dermatologii i venerologii,
V A Krylov, and O L Pokrovskaia, and T A Krylova, and N D Iarobkova
January 1995, Meditsina truda i promyshlennaia ekologiia,
V A Krylov, and O L Pokrovskaia, and T A Krylova, and N D Iarobkova
February 1984, Vrachebnoe delo,
V A Krylov, and O L Pokrovskaia, and T A Krylova, and N D Iarobkova
April 2005, Current opinion in infectious diseases,
Copied contents to your clipboard!